G. Krueger et al., The impact of psoriasis on quality of life - Results of a 1998 National Psoriasis Foundation Patient-Membership Survey, ARCH DERMAT, 137(3), 2001, pp. 280-284
Background: Psoriasis can have a profound impact on a patient's quality of
life.
Objectives: To assess patients' perspectives on the impact of psoriasis on
their lifestyle and emotional wellbeing and the social ramifications of liv
ing with the disease; to determine the range of therapies available; and to
ascertain patients' satisfaction with the management of their disease.
Design: A 4-page, self-administered questionnaire was mailed on July 13 and
14, 1998, to the entire membership of the National Psoriasis Foundation (N
=40350), and followed by a telephone survey of responders with severe psori
asis.
Main Outcome Measures: Patients' perspectives on the psychosocial impact of
psoriasis and the effectiveness of the management of their disease.
Results: Of the 40350 questionnaires mailed out, a response rate of 43% was
realized. The most frequent symp-toms experienced by the mail-survey respo
ndents were scaling (94%), itching (79%), and skin redness (71%); 39% repor
ted that psoriasis covered 10% or more of their bodies. A total of 6194 pat
ients with severe psoriasis were entered into the database for the telephon
e survey. Of these, 79% reported that psoriasis had a negative impact on th
eir lives, 40% felt frustrated with the ineffectiveness of their current th
erapies, and 32% reported that treatment was not aggressive enough.
Conclusions: The unprecedented response to the survey provides compelling e
vidence that individuals with psoriasis believe that the disease has a prof
ound emotional and social as well as physical impact on their quality of li
fe. Many patients with psoriasis, particularly those with severe disease, a
re frustrated with the management of their disease and by the perceived ine
ffectiveness of their therapies. Physicians may need to improve communicati
on with their patients and should reevaluate their management of psoriasis.